Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Co-Diagnostics Inc.

    NASDAQ: CODX · Real-Time Price · USD
    0.30
    -0.00 (-0.03%)
    At close: Jun 09, 2025, 3:59 PM
    -0.03%
    Bid 0.26
    Market Cap 10.11M
    Revenue (ttm) 1M
    Net Income (ttm) -35.86M
    EPS (ttm) -1.17
    PE Ratio (ttm) -0.26
    Forward PE -0.73
    Analyst Hold
    Ask 0.32
    Volume 435,320
    Avg. Volume (20D) 357,788
    Open 0.28
    Previous Close 0.30
    Day's Range 0.28 - 0.31
    52-Week Range 0.23 - 2.23
    Beta 0.58

    About CODX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CODX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CODX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts
    11 months ago
    +7.2%
    Co-Diagnostics shares are trading higher after the... Unlock content with Pro Subscription
    11 months ago
    +12.9%
    Co-Diagnostics shares are trading higher after the CDC announced free at home Covid 19 test delivery programs will reopen in late September.
    news image

    3 months ago · seekingalpha.com

    Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

    Co-Diagnostics, Inc. (NASDAQ:CODX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Andrew Benson - Head, Investor Relations Dwight Egan - Chief Executive Officer Brian Br...

    news image

    3 months ago · zacks.com

    Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates

    Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.31 per share a year ago.

    news image

    4 months ago · zacks.com

    All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy

    CoDiagnostics (CODX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

    news image

    4 months ago · zacks.com

    Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates

    Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.50 per share a year ago.

    news image

    4 months ago · seekingalpha.com

    Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

    Co-Diagnostics, Inc. (NASDAQ:CODX ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Andrew Benson - IR Dwight Egan - CEO Brian Brown - CFO Conference Call Participants ...

    Add to Watchlist